Evidence map›Paper›PMID 38665294›Full record

ArticleFrontiers in medicine2024

Perspectives on systematic capacity building in pharmaceutical regulation for regulators of medical products.

Luther Gwaza, Andrew Chemwolo, Mario Musonda, Rutendo Kuwana, Admire Dube

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Competencies for health technology assessment professionals: a scoping review and content analysis.International journal of technology assessment in health care · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Luther GwazaHealth Products Policy and Standards Department, Access to Medicines and Health Products Division, World Health Organization, Geneva, Switzerland.
Andrew ChemwoloRegulation and Prequalification Department, Access to Medicines and Health Products Division, World Health Organization, Geneva, Switzerland.
Mario MusondaRegulation and Prequalification Department, Access to Medicines and Health Products Division, World Health Organization, Geneva, Switzerland.
Rutendo KuwanaRegulation and Prequalification Department, Access to Medicines and Health Products Division, World Health Organization, Geneva, Switzerland.
Admire DubeSchool of Pharmacy, University of Western Cape, Cape Town, South Africa.
World Health Organization · CHUniversity of the Western Cape · ZA

Funding

FDA HHS U01 FD005031World Health Organization 001
6 · The paper itself

Abstract

Having a robust, integrated regulatory system is important for ensuring the availability of safe and efficacious medical products of good quality and for protecting public health. However, less than 30% of countries globally have reached the required regulatory maturity level three, with low- and middle-income countries facing challenges in attracting and retaining qualified staff. World Health Organization (WHO) advocates for systematic workforce development, including competency-based education, to address these gaps. We provide perspectives on a systematic approach to capacity building of medicine regulators based on the experience and lessons learnt in developing and piloting the WHO global competency framework for medicine regulators through three scenarios. A systematic approach to capacity building, such as the human performance technology model, can be used to implement the WHO competency framework as part of organizational performance improvement while ensuring that initiatives are well-defined, targeted, and aligned with organizational goals. The competency framework can be used in different contexts, such as improving organization performance for individual regulatory authorities, strengthening regional collaborations, harmonization and reliance on medical products assessment and joint good manufacturing practices inspections of pharmaceutical manufacturers, and developing learning programs for medicine regulators. A competency-based learning approach for regulatory professionals ensures the transfer of learning to the workplace by integrating real-world practices in learning activities and assessments. Further work is required to develop and validate the assessment instruments, apply the competency framework in other contexts, expanding the learning programmes while continuously providing feedback for further refinement of the competency framework and implementation support tools.

Indexed as

capacity buildingcompetency-based educationcompetency frameworkhuman performance improvementlearning programsmedicine regulatorspublic healthregulatory system

Identifiers

PMID38665294
PMCPMC11043567
OpenAlexW4394723088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.